-
-
-
-
-
-
-
Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Larimar Therapeutics (LRMR) PT Raised to $13 at Jones Trading
-
-
-
-
-
-
-
Larimar Therapeutics (LRMR) PT Lowered to $7 at Jones Trading
-
-
-
-
-
-
-
Guggenheim on Larimar Therapeutics (LRMR): 'remains on track to present initial OLE data in Sept 2025'
-
-
-
-
-
-
-
Citi on Larimar Therapeutics (LRMR): 'We are buyers on today’s weakness'
-
-
-
-
-
-
-
Larimar Therapeutics, Inc. (LRMR) Misses Q4 EPS by 14c
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Larimar Therapeutics (LRMR)
-
447,630 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

